pharmaphorum

MAY 23, 2025

Thousands of people living with rare kidney disease IgAN in the UK will soon be able to access a new oral treatment from CSL Vifor

80

80

Pharma Marketing Network

MAY 23, 2025

AI is no longer a novelty in pharma marketingits becoming a necessity. With the rising pressure to deliver compliant, engaging, and scalable campaigns, pharma marketers are turning to AI tools to streamline content creation, refine HCP targeting, and stay ahead of digital innovation. But with so many platforms emerging, how do teams choose which tools deliver real value?

Documentation 64

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

MAY 23, 2025

The Alzheimer's Association has hit out at "inaccurate and dangerous fabrications" by HHS Secretary Robert F Kennedy Jr about NIH dementia research

73

73

Pharmaceutical Technology

MAY 23, 2025

Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latters AI-driven screening algorithms.

66

66

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

pharmaphorum

MAY 23, 2025

GSK gets FDA approval for Nucala in COPD, setting up a marketing tussle with Sanofi/Regeneron's Dupixent

59

59

Pharmaceutical Commerce

MAY 23, 2025

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

52

52

Pharmaceutical Technology

MAY 23, 2025

An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea 8mg.

Labelling 52

Labelling 52

Pharmacy Times

MAY 23, 2025

After 3 predictive mortality tools demonstrate inefficiency within older adults with advanced chronic kidney disease (CKD), the authors call for the development of tools tailored for this population.

44

44

Pharmaceutical Commerce

MAY 23, 2025

Addressing drug shortages requires the industry to embrace innovative advanced manufacturing processes underpinned by real-time data.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

MAY 23, 2025

In a new pharmaphorum podcast, Rebecca Catterick, General Manager for Vaccines, UK & Ireland, at Sanofi, discusses the decline in vaccination rates, as well as what can be done to turn the situation around.

Vaccines 52

Vaccines 52

Pharmaceutical Commerce

MAY 23, 2025

Bruce Leuchter, CEO, Neurvati, discusses the indispensable role of patient advocatesparticularly in rare and serious disease drug developmentin shaping trial design, site selection, and regulatory strategy.

52

52

Pharmaceutical Technology

MAY 23, 2025

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their potential across a spectrum of interconnected conditions.

Drug Development 52

Drug Development 52

Pharmacy Times

MAY 23, 2025

Christian John Lillis discusses the 2025 Peggy Lillis Foundation C diff Summit, emphasizing the enduring need for community-building among survivors, the importance of sustained public health advocacy, and the growing urgency to defend federal health agencies amid political and institutional uncertainty.

44

44

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

MAY 23, 2025

Life sciences companies that can demonstrate unique value propositions, or show promising early signs of success, can earn investor confidence. Investors are willing to commit larger sums than ever before to companies they believe in.

52

52

Pharmaceutical Technology

MAY 23, 2025

The NICE has issued final draft guidance endorsing the use of CSL Vifor's Filspari (sparsentan) for primary IgA nephropathy.

52

52

Pharmacy Times

MAY 23, 2025

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

45

45

Pharmaceutical Technology

MAY 23, 2025

GSK has received approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab).

52

52

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

MAY 23, 2025

Changing Faces in Pharma and Biotech hires in April 2025 feature renowned companies like Novo Nordisk, Galapagos, Transgene, Telix and more. Stay updated on the latest industry movements and key appointments.

52

52

Pharmacy Times

MAY 23, 2025

Physical activity significantly enhanced quality of life and reduced fatigue and depression in patients with newly diagnosed multiple myeloma.

33

33

pharmaphorum

MAY 23, 2025

Register Now for AAPS PharmSci 360! Sara.

52

52

Pharmacy Times

MAY 23, 2025

A panelist discusses how clinical trials and institutional guidelines have improved the management of infusion-related reactions (IRRs) through standardized premedication protocols, including the SKIPPirr trial, which demonstrated that home dexamethasone use prior to amivantamab infusions can significantly reduce reaction rates from 67% to 22.5%.

26

26

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharma Marketing Network

MAY 23, 2025

When someone you love is diagnosed with HIV, the impact can ripple through the entire household. Whether its a partner, parent, sibling, or child, supporting a family with HIV brings emotional, practical, and sometimes medical challenges. It also brings opportunitiesto show compassion, to fight stigma, and to grow stronger together. In 2025, advances in antiretroviral therapy (ART), public awareness, and long-term care models have drastically improved the quality of life for people living with H

Communication 52

Communication Immunization Immunity 52

Pharmacy Times

MAY 23, 2025

Interventions such as educational brochures, provider-delivered educational programs, and computerized reminders were found to help improve pneumococcal vaccine uptake in older adults.

Vaccines 26

Vaccines 26

Pharmaceutical Technology

MAY 23, 2025

The new OS results came from the Phase III INAVO120 study evaluating an Itovebi triple combination therapy.

52

52

Pharmacy Times

MAY 23, 2025

A panelist discusses how evidence-based protocols for managing infusion-related reactions have reduced hesitancy among health care providers to use agents like amivantamab, empowered the entire care team with knowledge, and balanced the benefits and challenges of oral vs intravenous (IV) chemotherapy administration in relation to patient autonomy, adherence, and quality of life.

Chemotherapy 26

Chemotherapy 26

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 23, 2025

Before it became a national scandal, the lead-poisoning-from-applesauce case was just two little kids with concerning blood test results in Hickory, N.C. A state inspector drove out with local health officials in June 2023 to try to find the source. He powered up his X-ray fluorescence analyzer — like a cross between a laser gun and a power tool — which emitted a beam that dislodges electrons, coaxing out chemical fingerprints, and pointed it at surface after surface.

363

363

Pharmacy Times

MAY 23, 2025

Panelists discuss how second-line therapy selection and individualized care strategies are essential in chronic graft-vs-host disease (cGVHD) management, emphasizing the need to reduce steroid-related toxicity, address patient-specific factors, and leverage pharmacist expertise to optimize outcomes.

26

26

STAT

MAY 23, 2025

In 1975, my sister Robin, at 19, became a living kidney donor for our brother.  A few years later, we backpacked through Europe. She later married, had two beautiful children, and launched a successful business. But the donation affected her long-term health. When she was diagnosed with breast cancer at 46 in 2002, Robin declined chemotherapy , fearing it might damage her remaining kidney.

Chemotherapy 302

Chemotherapy 302